Search research articles
Contact Us
Filters
Showing results (31-40 of 85) with videos related to
Page
of 9
Sort By:
Cancer Treatment Reports
|
November 1, 1985
Tastes associated with parenteral chemotherapy for breast cancer
J H Fetting, P M Wilcox, V R Sheidler, et al.
Journal of the National Cancer Institute
|
July 6, 1988
Clinical pharmacology of oral and i.v. N-methylformamide: a pharmacologic basis for lack of clinical antineoplastic activity
E K Rowinsky, D A Noe, D W Orr, et al.
Blood
|
November 11, 1992
Optimization of busulfan dosage in children undergoing bone marrow transplantation: a pharmacokinetic study of dose escalation
A M Yeager, J E Wagner, M L Graham, et al.
Cancer
|
April 15, 1984
Acute anthracycline cardiotoxicity. Comparative morphologic study of three analogues
A L Taylor, M M Applefeld, P H Wiernik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1993
Regional chemotherapy devices: effect of experience and anatomy on complications
K A Campbell, R C Burns, J V Sitzmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1986
Phase I and pharmacologic study of hexamethylene bisacetamide in patients with advanced cancer
E K Rowinsky, D S Ettinger, L B Grochow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1996
Phase I and pharmacologic study of high doses of the topoisomerase I inhibitor topotecan with granulocyte colony-stimulating factor in patients with solid tumors
E K Rowinsky, L B Grochow, S E Sartorius, et al.
Cancer Research
|
November 15, 1992
Intrathecal 4-hydroperoxycyclophosphamide: neurotoxicity, cerebrospinal fluid pharmacokinetics, and antitumor activity in a rabbit model of VX2 leptomeningeal carcinomatosis
P C Phillips, T T Than, L C Cork, et al.
Cancer Chemotherapy and Pharmacology
|
July 8, 1998
Increased 9-aminocamptothecin dose requirements in patients on anticonvulsants. NABTT CNS Consortium. The New Approaches to Brain Tumor Therapy
S A Grossman, F Hochberg, J Fisher, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1994
Relation between age and clearance rate of nine investigational anticancer drugs from phase I pharmacokinetic data
J M Borkowski, M Duerr, R C Donehower, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 85) with videos related to
Sort By:
Page
of 9
Cancer Treatment Reports
|
November 1, 1985
Tastes associated with parenteral chemotherapy for breast cancer
J H Fetting, P M Wilcox, V R Sheidler, et al.
Journal of the National Cancer Institute
|
July 6, 1988
Clinical pharmacology of oral and i.v. N-methylformamide: a pharmacologic basis for lack of clinical antineoplastic activity
E K Rowinsky, D A Noe, D W Orr, et al.
Blood
|
November 11, 1992
Optimization of busulfan dosage in children undergoing bone marrow transplantation: a pharmacokinetic study of dose escalation
A M Yeager, J E Wagner, M L Graham, et al.
Cancer
|
April 15, 1984
Acute anthracycline cardiotoxicity. Comparative morphologic study of three analogues
A L Taylor, M M Applefeld, P H Wiernik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1993
Regional chemotherapy devices: effect of experience and anatomy on complications
K A Campbell, R C Burns, J V Sitzmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1986
Phase I and pharmacologic study of hexamethylene bisacetamide in patients with advanced cancer
E K Rowinsky, D S Ettinger, L B Grochow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1996
Phase I and pharmacologic study of high doses of the topoisomerase I inhibitor topotecan with granulocyte colony-stimulating factor in patients with solid tumors
E K Rowinsky, L B Grochow, S E Sartorius, et al.
Cancer Research
|
November 15, 1992
Intrathecal 4-hydroperoxycyclophosphamide: neurotoxicity, cerebrospinal fluid pharmacokinetics, and antitumor activity in a rabbit model of VX2 leptomeningeal carcinomatosis
P C Phillips, T T Than, L C Cork, et al.
Cancer Chemotherapy and Pharmacology
|
July 8, 1998
Increased 9-aminocamptothecin dose requirements in patients on anticonvulsants. NABTT CNS Consortium. The New Approaches to Brain Tumor Therapy
S A Grossman, F Hochberg, J Fisher, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1994
Relation between age and clearance rate of nine investigational anticancer drugs from phase I pharmacokinetic data
J M Borkowski, M Duerr, R C Donehower, et al.
Page
of 9